<?xml version="1.0" encoding="UTF-8"?>
<p>Previous research efforts to develop anti‐viral agents against members of Coronaviridae family demonstrated that the Angiotensin‐converting enzyme II (ACE2) entry receptor, the RNA‐dependent RNA polymerase (RdRp) and the main protease (Mpro) proteins may represent suitable drug targets.
 <xref rid="minf202000028-bib-0007" ref-type="ref">7</xref> Although initially promising, inhibitors targeting ACE2 (hence aiming to block critical coronavirus‐host interactions) did not advance clinically due to significant side effects.
 <xref rid="minf202000028-bib-0008" ref-type="ref">8</xref> Likewise, RdRp inhibitors appeared to be not very specific and demonstrated overall lower potency, that also translated into common side effects in patients.
 <xref rid="minf202000028-bib-0001" ref-type="ref">1</xref>, 
 <xref rid="minf202000028-bib-0009" ref-type="ref">9</xref> Nevertheless, rapid drug repurposing efforts have identified Remdesivir, a RdRp inhibitor, as a promising antiviral drug against COVID‐19.
 <xref rid="minf202000028-bib-0010" ref-type="ref">10</xref>, 
 <xref rid="minf202000028-bib-0011" ref-type="ref">11</xref> Clinical trials are currently ongoing to determine the full efficacy spectrum of the compound in patients (clinicaltrials.gov, NCT04280705
 <xref rid="minf202000028-bib-0012" ref-type="ref">12</xref>). Concurrently, CoV infected patients administered with protease inhibitors, lopinavir/ritonavir, have shown improved outcome,
 <xref rid="minf202000028-bib-0001" ref-type="ref">1</xref>, 
 <xref rid="minf202000028-bib-0013" ref-type="ref">13</xref> demonstrating the potential of the main protease (Mpro) as the most promising drug target in CoVs
 <xref rid="minf202000028-bib-0014" ref-type="ref">14</xref>, 
 <xref rid="minf202000028-bib-0015" ref-type="ref">15</xref> Hence, a recently published X‐ray crystal structure of the SARS‐CoV‐2 Mpro provides an excellent ground for structure‐based drug discovery efforts.
 <xref rid="minf202000028-bib-0016" ref-type="ref">16</xref>
</p>
